It has been reported that the loss expression of CD86, which was implicated in controlling tumor growth, was associated with decreased tumor-infiltrating T lymphocytes (T-TILs) in DLBCL patients (39). The gene discussed is CD86; the disease is diffuse large B-cell lymphoma.